HCV infection, HOMA index and sustained virological response: the step we need to take before moving forward. - Suppr | 超能文献

HCV infection, HOMA index and sustained virological response: the step we need to take before moving forward.

作者信息

La Mura Vincenzo, Persico Marcello

出版信息

J Hepatol. 2012 Aug;57(2):472; author reply 473. doi: 10.1016/j.jhep.2012.02.009. Epub 2012 Mar 3.

DOI:10.1016/j.jhep.2012.02.009

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

HCV infection, HOMA index and sustained virological response: the step we need to take before moving forward.

J Hepatol. 2012 Aug;57(2):472; author reply 473. doi: 10.1016/j.jhep.2012.02.009. Epub 2012 Mar 3.

2

Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance.

Liver Int. 2010 Mar;30(3):447-54. doi: 10.1111/j.1478-3231.2009.02171.x. Epub 2009 Nov 16.

3

Hyperinsulinaemia reduces the 24-h virological response to PEG-interferon therapy in patients with chronic hepatitis C and insulin resistance.

J Viral Hepat. 2010 Jul;17(7):475-80. doi: 10.1111/j.1365-2893.2009.01204.x.

4

Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis.

J Hepatol. 2011 Dec;55(6):1187-94. doi: 10.1016/j.jhep.2011.03.010. Epub 2011 Apr 13.

5

Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin.

J Hepatol. 2009 Dec;51(6):984-90. doi: 10.1016/j.jhep.2009.07.008. Epub 2009 Jul 23.

6

Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment Group.

Am J Gastroenterol. 2000 Oct;95(10):2928-35. doi: 10.1111/j.1572-0241.2000.02321.x.

7

Interferon alpha-2b in combination with ribavirin for the treatment of chronic hepatitis C: assessment of virological, biochemical and histological treatment response.

Medicina (Kaunas). 2004;40(6):538-46.

8

Pioglitazone in chronic hepatitis C not responding to pegylated interferon-alpha and ribavirin.

J Hepatol. 2008 Aug;49(2):295-8. doi: 10.1016/j.jhep.2008.03.033. Epub 2008 May 22.

9

Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1.

Gut. 2012 Oct;61(10):1473-80. doi: 10.1136/gutjnl-2011-300749. Epub 2012 Mar 2.

10

DOES INSULIN RESISTANCE IMPAIR THE VIROLOGICAL RESPONSE TO PEGINTERFERON/RIBAVIRIN IN CHRONIC HEPATITIS C GENOTYPE 3 PATIENTS?

Arq Gastroenterol. 2018 Apr-Jun;55(2):179-183. doi: 10.1590/S0004-2803.201800000-32.